Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness

被引:54
作者
Chaiswing, Luksana
Bourdeau-Heller, Jeanne M.
Zhong, Weixiong
Oberley, Terry D.
机构
[1] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Madison, WI 53705 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA
关键词
cell growth; LNCaP; PC3; redox state; free radicals;
D O I
10.1016/j.freeradbiomed.2007.03.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We characterized the redox profiles in two different human prostate carcinoma cell lines (LNCaP vs PC3) that are known to exhibit varying degrees of invasiveness/metastatic ability. We confirmed that PC3 cells were more in-vasive than LNCaP cells through an in vitro analysis. The present study documented higher 8-hydroxy-2'-deoxyguanosine levels in PC3 cells than in LNCaP cells. The levels of lipid peroxidation were higher in LNCaP cells than in PC3 cells. The reduced glutathione (GSH)/glutathione disulfide (GSSG) ratio increased to a greater extent during cell growth in PC3 cells than in LNCaP cells, whereas both reduced GSH and GSSG levels were higher in the medium of PC3 cells than in that of LNCaP cells. The levels of reactive oxygen (ROS) and reactive nitrogen species (RNS), both intracellularly and in the medium, were higher for LNCaP cells than for PC3 cells during cell growth. In addition, our results demonstrated higher ROS/RNS levels in LNCaP cells than in PC3 cells in S and G2/M phases of the cell cycle during logarithmic growth. Each cell type showed distinct cytotoxic responses to low-molecular-weight redox-modulating compounds. Our results document that human prostate cancer cell lines of varying degrees of aggressive behavior have distinct redox properties, findings that could lead to novel therapeutic interventions. Published by Elsevier Inc.
引用
收藏
页码:202 / 215
页数:14
相关论文
共 46 条
[1]   Mitochondrial O2-• and H2O2 mediate glucose deprivation-induced cytotoxicity and oxidative stress in human cancer cells [J].
Ahmad, IM ;
Aykin-Burns, N ;
Sim, JE ;
Walsh, SA ;
Higashikubo, R ;
Buettner, GR ;
Venkataraman, S ;
Mackey, MA ;
Flanagan, SW ;
Oberley, LW ;
Spitz, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4254-4263
[2]   Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells [J].
Bataller, M ;
Portugal, J .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 437 (02) :151-158
[3]  
Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO
[4]  
2-9
[5]  
Chen Y, 2001, CANCER RES, V61, P4112
[6]   Oxidative stress and apoptosis: a new treatment paradigm in cancer [J].
Engel, RH ;
Evens, AM .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :300-312
[7]   Measuring reactive species and oxidative damage in vivo and in cell culture:: how should you do it and what do the results mean? [J].
Halliwell, B ;
Whiteman, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (02) :231-255
[8]   Oxidative stress and cancer: have we moved forward? [J].
Halliwell, Barry .
BIOCHEMICAL JOURNAL, 2007, 401 (1-11) :1-11
[9]  
HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
[10]   Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells [J].
Huss, WJ ;
Gray, DR ;
Greenberg, NM ;
Mohler, JL ;
Smith, GJ .
CANCER RESEARCH, 2005, 65 (15) :6640-6650